Related Experiment Videos
Cardiopulmonary bypass and complement activation. Involvement of classical and alternative pathways
Anaesthesia
|June 1, 1982
Summary
Cardiopulmonary bypass activates the complement system, consuming key components like C3, C4, and factor B. Steroid therapy does not prevent this activation, which is primarily driven by the classical pathway.
Area of Science:
- Immunology
- Cardiovascular Surgery
Background:
- Cardiopulmonary bypass (CPB) is a critical procedure in cardiac surgery.
- The complement system is a vital part of innate immunity.
- CPB may trigger immune responses, including complement activation.
Purpose of the Study:
- To investigate complement system activation during CPB.
- To identify complement components consumed during CPB.
- To determine the pathway of complement activation and the effect of steroid therapy.
Main Methods:
- Analysis of complement components (C3, C4, factor B) in patient sera.
- Comparison between bubble and membrane oxygenators.
- Assessment of steroid therapy's impact on complement activation.
Main Results:
- Complement activation was observed during CPB, with significant consumption of C3, C4, and factor B.
- Both bubble and membrane oxygenators induced complement activation.
- Steroid therapy did not attenuate complement activation.
- Evidence suggests predominant activation via the classical pathway, potentially linked to IgM aggregates.
Conclusions:
- Cardiopulmonary bypass robustly activates the complement system.
- Complement activation during CPB is independent of steroid administration.
- The classical pathway is likely the primary route of activation, possibly influenced by IgM.
- Further research into mitigating complement activation during CPB is warranted.